Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 09/10/2021

Closing price: 70.99

Support price level:	$70.77
Resistance price level:	N/A
Relative strength index (14-day RSI)	40.7
Beta	0.19

GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
The price of this low-beta stock is expected to increase by 0.19% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$56.65	$73.03	88.8%

200 day	50 day	20 day	10 day
$65.93	$70.04	$71.83	$71.69

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
26.7%	21.9%	22.3%	25.4%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: